Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
Completed
×
cabozantinib
×
Clear all
Filters
3
NCT04338269
2025-04-04
CONTACT-03
Hoffmann-La Roche
Phase 3
Completed
522 enrolled
18 charts
NCT01908426
2021-05-06
CELESTIAL
Exelixis
Phase 3
Completed
707 enrolled
20 charts
1 FDA
NCT01865747
2021-04-27
METEOR
Exelixis
Phase 3
Completed
658 enrolled
15 charts